Purpose: In gingival squamous cell carcinoma (GSCC), the association between survival and history of dental extraction (DE) is controversial.
Introduction
Teeth that are in close proximity to a carcinoma can be associated with swelling, pain, and loosening, and may thus be erroneously extracted because of suspected periodontitis or pericoronitis by the dental general practitioner. Suzuki et al. reported that, compared to a group of patients in whom dental extraction (DE) was not performed, the incidence of pathologically positive lymph nodes was significantly higher and the five-year survival rate lower in a DE-treated group. 1 Moreover, when DE is performed for incorrectly diagnosed periodontitis or pericoronitis, the correct diagnosis and appropriate treatment may be delayed, resulting in a worse prognosis. Previous studies suggest that the risks of gingival squamous cell carcinoma (GSCC) recurrence, cervical lymph-node metastasis, and distant metastases are increased in patients with a history of DE. 1, 2 However, the association between survival and a history of DE remains controversial. Other researchers have reported that DE does not influence local control, lymph-node metastasis, distant metastasis, or disease-specific survival prior to definitive treatment. [3] [4] [5] Lubek et al. reported that previous DE, which can potentially seed the open socket with cancer cells and allow deep bony involvement, was not a significant variable. 6 Thus, although the risks of DE have been emphasized, its effects on the metastasis and prognosis of patients have not been well documented. This study was carried out to investigate the prognosis of GSCC detected after DE was performed at the site of the carcinoma.
Patients and Methods

Subjects
Seventy-seven patients, 45 men and 32 women, in whom GSCC was diagnosed at the Department of Oral and Maxillofacial Surgery, University of Tsukuba Hospital, between 1997 and 2008, were retrospectively enrolled as subjects. All the cases were reviewed for an approximately 5-year period after each patient's first visit or radical treatment. Patients' ages ranged from 40 to 88 years, with a median of 70 years. The primary tumor site was the maxilla for 25 cases and the mandible for 52 cases. Each patient's cancer was staged according to the 1997 International Union Against Cancer (UICC) categories. The treatment modality given for the primary tumor included surgery, radiotherapy, chemotherapy, or a combination. The primary tumor was excised with a safety margin greater than 10 mm in all directions. The extent of bone resection (marginal or segmental) was based on the extent of the soft-tissue tumor and of the radiographically determined bone invasion. DE within the tumor was performed in 19 patients (24.7%) before diagnosis (DE group) and was not performed in 58 patients (75.3%) (non-DE group). The clinical features, characteristics, and prognosis were evaluated for statistical differences between the two groups. The patients' data were examined retrospectively by reviewing their medical records. Due to the retrospective nature of this study, it was granted an exemption in writing by the University of Tsukuba Hospital. The following information was obtained: age, sex, site of primary tumor (maxilla or mandible), locoregional treatment, history of DE before diagnosis, symptoms at first visit, and 5-year survival rate according to the primary tumor site.
Statistical analysis
Survival curves were calculated by the Kaplan-Meier method, and difference in the survival rate was determined with the Log-rank test. The Mann-Whitney U-test and Chi square test were used in statistical comparisons between the DE group and non-DE group. All statistical analyses were performed with the Stat View J 5.0 software package (SAS Institute Inc, Chicago IL). Differences with a p-value less than 0.05 were considered statistically significant.
Results
Patient characteristics
The tumor status in the DE group was T2 for 5 patients, T3 for 4, and T4 for 10; in the non-DE group, it was T1 for 3 patients, T2 for 22, T3 for 9, and T4 for 24. The node status in the DE group was N0 for 11 patients, N1 for 4, and N2b for 4; in the non-DE group, it was N0 for 37 patients, N1 for 6, N2b for 10, and N2c for 5. The cancer stage in the DE group was stage II for 3 patients, stage III for 4, and stage IV for 12; 5 in the non-DE group, it was stage I for 1 patient, stage II for 20, stage III for 8, and stage IV for 29. There was no significant difference in stage classification between the DE and non-DE groups ( Table 1) .
Patients undergoing DE before diagnosis and clinical features of both groups at first visit
DE within the tumor was performed in 19 patients before GSCC was diagnosed, at another hospital.
The interval between DE and the first visit to our hospital was 1.1-97 weeks, with a median of 7.3 weeks.
The extraction site was the maxilla in 6 patients (11 teeth) and the mandible in 13 patients (19 teeth). The tooth position was anterior in 3 patients (7 teeth) and molar in 16 patients (23 teeth).
The major symptom was swelling in both the DE and non-DE groups (52.6%, 53.4%). Pain (21.1%) and delay of extraction site healing (15.8%) were the next most common symptoms in the DE group. Poor denture fit (15.5%) and ulceration (12.1%) were the next most common symptoms in the non-DE group.
Radiographically, bone invasion was observed in all the patients in the DE group and in 37 patients
(63.8%) in the non-DE group. Bone invasion of mandibular GSCC was observed in 6 patients (100%) in the DE group and 13 patients (68.4%) in the non-DE group. There was a significant difference in the bone invasion between the DE and non-DE groups (P<0.01) ( Table 2 ).
Locoregional treatment and surgical procedure
The locoregional treatment in the DE group was surgery for 13 patients, pre-surgical radiotherapy and surgery for 4, surgery and post-surgical radiotherapy for 1, and radiotherapy for 1; in the non-DE group, the treatment was surgery for 31 patients, pre-surgery radiotherapy and surgery for 17, surgery and post-surgery radiotherapy for 2, and radiotherapy for 8 (Table 1 ). There was no significant difference in any of these factors between the two groups.
Surgery was performed in 21 patients with GSCC of the maxilla and 47 with GSCC of the mandible.
Marginal mandibulectomy was performed in 2 patients (15.4%) in the DE group and 13 (38.2%) in the non-DE group. Segmental mandibulectomy was performed in 11 patients (84.6%) in the DE group and 21 (61.8%) in the non-DE group. Although the extent of resection tended to be larger for the DE group, the 6 difference between the groups was not statistically significant. The surgical procedure for the maxilla is shown in Table 3 . Neck dissection was performed in 11 patients in the DE group and 25 patients in the non-DE group (Table 3) .
Pathologically, the surgical margin was free of cancer in 16 patients (88.9%) in the DE and 43 patients (Table 4 ).
Postsurgical course and survival rate of each group
Sixteen patients had a local recurrence during the postsurgical course (4 patients in the DE group and 12 in the non-DE group); 8 had late neck metastasis, and 9 had distant metastasis. The difference in postsurgical course between the DE and non-DE groups was not statistically significant ( Fig 1) .
Among the mandibular gingival cancer patients, the survival rate was 84.6% in the DE group and 65.8% in the non-DE group, which was not significantly different ( Table 6 , Fig 2) .
Discussion
Pain is reported to be the most common clinical feature of GSCC diagnosed after DE, present in all such cases. 7 In our study, pain was a symptom in 21.1% of the patients in the DE group, consistent with the previous report, and 8.6% in the non-DE group. The duration of symptoms before DE is reported to range from 3 weeks to 20 months, with most patients seeking treatment at 3 months. 7 The mean time interval between DE and histologic diagnosis in a previous report was 63 days (9 weeks) with a range of 3 to 260 days (0.4-37 weeks). 1 In this study, the interval between DE and the first visit was 1.1-97 weeks, with a median of 7.3 weeks. Symptoms appeared in these patients about 2 months after DE, which was almost the same as in previous reports. This delay may be one of the factors that facilitate tumor dissemination. Suzuki et al. suggested that the delay in symptoms increases the risk of lymph-node metastasis and contributes to a poor prognosis. 1 In the present study, it was not clear whether this delay affected the lymph-node metastasis or prognosis.
The association between prognosis and history of DE remains controversial. It has been hypothesized that a history of previous DE worsens the prognosis, and neck node metastasis was reported to be more frequent in patients who underwent DE. 1 However, other authors reported that cervical lymph node metastasis was not significantly different between patients who underwent an invasive procedure and those who did not. 3, 5 In addition, statistically significant differences were not found in the tumor recurrence rate, cervical recurrence, distant metastasis, or 5-year survival rate. 3, 5 Lubek et al. reported that previous DE, which can theoretically seed the open socket and allow deep bony involvement, was not a significant variable for the prognosis for gingival carcinoma. 6 In the present study, we found no differences in the T status, N status, local recurrence, or distant metastasis with or without DE. Mandibular GSCC showed almost the same prognosis in the DE and non-DE groups. These results supported the latter opinions. On the other hand, there was a significant difference in the survival rate of patients with maxillary GSCC between the DE and non-DE groups. However, the sample size was small for the maxillary cases, and further studies with a larger number of cases at this primary site will be required to clarify the difference.
In a previous report, advanced clinical stage III and IV, previous DE, bony invasion, and invaded margins were associated with worse survival in a univariate analysis. 8 Only the difference in advanced stage was significant in multivariate analysis, but lymph-node involvement was not studied separately. 8 Although bone invasion is reported to be a predictive factor, a recent study showed that tumors with bone invasion limited to the cortex have a similar prognosis to those without bone invasion. 9 Surgical invasiveness in oral cancer, including biopsy, causes the dissemination of cancer cells into the circulation, increasing the risk for metastasis. 2 In general, cervical lymph-node metastasis is one of the most significant factors affecting the prognosis of head and neck cancer. In the present study, the incidence of cervical lymph-node metastasis was 42.1% in the DE group and 36.2% in the non-DE group, which, although it was not significantly different, could have affected the overall survival rates of these two groups. On the other hand, another group reported that the disease-specific survival rates of two groups that had or had not undergone surgical procedures before GSCC treatment were not significantly different. This conclusion was based on the extent of resection needed for the primary tumor. 4 Cancer bone invasion is a well-known predictive factor for survival. 8 Hong et al. advised using more aggressive resection, when a GSCC in the dentate mandible remains undiagnosed for a few months after inadvertent DE or when a secondary surgical manipulation was previously carried out at the tumor site. 10 When the malignant tumor is related to previous DE or curettage, it tends to be more extensive than predicted from imaging. If mandibular invasion by GSCC is identified radiographically and clinically, segmental mandibulectomy is required for an adequate safety margin, considering the spreading pattern in the molar region. 10 In the present mandibular GSCC cases, previous DE did not affect the T stage. The resection field in the patients who received DE tended to be broader; for instance, the proportion of patients who received segmental mandibulectomy was 84.6% in the DE group versus 61.8% in the non-DE group. In addition, the extent of radiographically detected bone invasion was significantly greater in the DE group. Although the extent of bone resection was determined from clinical and radiographic criteria, surgeons may have believed that the DE patients had more locally disseminated microscopic disease, leading them to choose segmental mandibulectomy. This choice may have biased the data to some extent. Thus, the extended resection field might have been related to the lack of significant difference in the 5-year overall survival rate between the two groups.
In the cases of maxillary GSCC, there was a significant difference in the survival rates, 33.3% in the DE group and 73.7% in the non-DE group. Although the T status as detected by CT or MRI was not affected in the DE group, it is likely that microscopic GSCC extended into the cancellous bone of the maxilla.
According to a report, the extent of bony invasion diagnosed clinically and radiographically often does not 
